Viral particles which are released after the infection with the human cytomegalovirus and the use of said particles as a vaccine
CA 2365903 C · Owner: Plachter, Bodo · Inventors: Plachter, Bodo
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to viral particles which are released by mammal cells after the infection with the human cytomegalovirus (HCMV). The invention also relates to particles whose antigenicity has been optimised by changing the HMCV using genetic engineering. The invention further relates to the use of such particles as a vaccine and to a method for multiplying the HCMV in mammal cells.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 2, 2000 and granted February 12, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 2, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 2, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.